PHASE II

Clinical trials for PHASE II explained in plain language.

Never miss a new study

Get alerted when new PHASE II trials appear

Sign up with your email to follow new studies for PHASE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug aims to tame rare blood cancers in 30-patient trial

Disease control Not yet recruiting

This study tests a drug called imetelstat in 30 adults with certain blood cancers (MDS/MPN) that haven't responded to standard treatments. The goal is to see if the drug can help control the disease and to check for side effects. Participants must be 18 or older and meet specific…

Matched conditions: PHASE II

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 01, 2026 16:00 UTC

PHASE II

Get alerted when new PHASE II trials appear

New drug aims to tame rare blood cancers in 30-patient trial